Skip to main content
Erschienen in: Surgery Today 9/2015

01.09.2015 | Original Article

Initial experiences with MR Image-guided laparoscopic microwave coagulation therapy for hepatic tumors

verfasst von: Koichiro Murakami, Shigeyuki Naka, Hisanori Shiomi, Hiroya Akabori, Yoshimasa Kurumi, Shigehiro Morikawa, Tohru Tani

Erschienen in: Surgery Today | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Percutaneous thermal ablation is used for treating hepatic tumors. Recent advances in laparoscopy and imaging modalities have led to the development of a novel image-guided minimally invasive loco-regional treatment. The aim of this trial was to apply laparoscopic assistance to magnetic resonance (MR) image-guided thermoablation instead of ultrasonography, because of its various advantages.

Methods

Patients with hepatic tumors and liver cirrhosis underwent magnetic resonance (MR) image-guided laparoscopic microwave coagulation therapy using a borescope and endoscopic forceps. Six cases of laparoscopic microwave coagulation treatment using MR image guidance were successfully performed between January 2000 and December 2008. Tumors were detected, punctured, and ablated in an open-configured MR scanner. A total of nine hepatocellular carcinoma nodules were preoperatively identified in S3, S5 and S6 (mean diameter = 20.8 ± 5.4 mm).

Results

MR-guided microwave coagulation was laparoscopically achieved in all patients without any significant complications that required invasive treatment. The mean length of the operation was 275.3 ± 60.5 min, and the mean postsurgical hospital stay was 10.0 ± 2.3 days. Postoperative confirmation scanning was performed without moving the patients.

Conclusion

MR-guided laparoscopic microwave coagulation therapy is an effective treatment for hepatic tumors adjacent to other organs, as it allows for more accurate detection of lesions and for tumors to be treated safely while avoiding adjacent organs. It is less invasive than conventional procedures, because the MR real-time guidance enabled continuous monitoring throughout the procedure.
Literatur
1.
Zurück zum Zitat Seifert JK, Junginger T, Morris Dl. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb. 1998;43:141–54.PubMed Seifert JK, Junginger T, Morris Dl. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb. 1998;43:141–54.PubMed
2.
Zurück zum Zitat Gilbert JC. Current advances in interventional MRI guided cryosurgery. Eur Radiol. 1997;7:1165. Gilbert JC. Current advances in interventional MRI guided cryosurgery. Eur Radiol. 1997;7:1165.
3.
Zurück zum Zitat Mack MG, Straub R, Eichler K, Engelmann K, Zangos S, Roggan A, et al. Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom Imaging. 2001;26:369–74.CrossRefPubMed Mack MG, Straub R, Eichler K, Engelmann K, Zangos S, Roggan A, et al. Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom Imaging. 2001;26:369–74.CrossRefPubMed
4.
Zurück zum Zitat Rossi S, Di Stasi M, Buscarini E, Cavanna L, Quaretti P, Squassante E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am. 1995;1(1):73–81.PubMed Rossi S, Di Stasi M, Buscarini E, Cavanna L, Quaretti P, Squassante E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am. 1995;1(1):73–81.PubMed
5.
Zurück zum Zitat Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg. 2002;235:466–86.PubMedCentralCrossRefPubMed Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg. 2002;235:466–86.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Ido K, Isoda N, Sugano K. Microwave coagulation therapy for liver cancer: laparoscopic microwave coagulation. J Gastroenterol. 2001;36:145–52.CrossRefPubMed Ido K, Isoda N, Sugano K. Microwave coagulation therapy for liver cancer: laparoscopic microwave coagulation. J Gastroenterol. 2001;36:145–52.CrossRefPubMed
7.
Zurück zum Zitat Stattner S, Primavesi F, Yip VS, Jones RP, Ofner D, Malik HZ, et al. Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience. Surg Today 2014 (Online First). Stattner S, Primavesi F, Yip VS, Jones RP, Ofner D, Malik HZ, et al. Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience. Surg Today 2014 (Online First).
8.
Zurück zum Zitat Head HW, Dodd GD III. Thermal ablation for hepatocellular carcinoma. Gastroenterology. 2004;127:167–78.CrossRef Head HW, Dodd GD III. Thermal ablation for hepatocellular carcinoma. Gastroenterology. 2004;127:167–78.CrossRef
9.
Zurück zum Zitat Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005;14:41–52.CrossRefPubMed Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005;14:41–52.CrossRefPubMed
10.
Zurück zum Zitat Cillio U, Vitale A, Dupuis D, Corso S, Neri D, Damico, et al. Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: A cohort study. PLoS One 2013;8(2):1–8. Cillio U, Vitale A, Dupuis D, Corso S, Neri D, Damico, et al. Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: A cohort study. PLoS One 2013;8(2):1–8.
11.
Zurück zum Zitat Santambrogio R, Opocher E, Montorsi M. Laparoscopic radiofrequency ablation of hepatocellular carcinoma: a critical review from the surgeon’s perspective. J Ultrasound. 2008;11:1–7.PubMedCentralCrossRefPubMed Santambrogio R, Opocher E, Montorsi M. Laparoscopic radiofrequency ablation of hepatocellular carcinoma: a critical review from the surgeon’s perspective. J Ultrasound. 2008;11:1–7.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Seki S, Sakaguchi H, Iwai S, Kadoya H, Kabayashi S, Kitada T, et al. Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy. Endoscopy. 2005;37(12):1220–5.CrossRefPubMed Seki S, Sakaguchi H, Iwai S, Kadoya H, Kabayashi S, Kitada T, et al. Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy. Endoscopy. 2005;37(12):1220–5.CrossRefPubMed
13.
Zurück zum Zitat Imura S, Shimada M, Utsunomiya T, Morine Y, Wakabayashi G, Kaneko H. Current status of laparoscopic liver surgery in Japan: results of a multicenter Japanese experience. Surg Today. 2014;44(7):1214–9.CrossRefPubMed Imura S, Shimada M, Utsunomiya T, Morine Y, Wakabayashi G, Kaneko H. Current status of laparoscopic liver surgery in Japan: results of a multicenter Japanese experience. Surg Today. 2014;44(7):1214–9.CrossRefPubMed
14.
Zurück zum Zitat Jolesz FA, Morrison PR, Koran SJ, Kelley RJ, Hushek SG, Newman RW, et al. Compatible instrumentation for intraoperative MRI: expanding resources. J Magn Reson Imaging. 1998;8(1):8–11.CrossRefPubMed Jolesz FA, Morrison PR, Koran SJ, Kelley RJ, Hushek SG, Newman RW, et al. Compatible instrumentation for intraoperative MRI: expanding resources. J Magn Reson Imaging. 1998;8(1):8–11.CrossRefPubMed
15.
Zurück zum Zitat Moscatel MA, Shellock FG, Morisoli SM. Biopsy needles and devices: assessment of ferromagnetism and artifacts during exposure to a 1.5-T MR system. J Magn Reson Imaging. 1995;5(3):369–72.CrossRefPubMed Moscatel MA, Shellock FG, Morisoli SM. Biopsy needles and devices: assessment of ferromagnetism and artifacts during exposure to a 1.5-T MR system. J Magn Reson Imaging. 1995;5(3):369–72.CrossRefPubMed
16.
Zurück zum Zitat Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Tani T, et al. MR-guided microwave thermocoagulation therapy of liver tumors: initial clinical experiences using a.5 T open MR system. J Magn Reson Imaging. 2002;16:576–83.CrossRefPubMed Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Tani T, et al. MR-guided microwave thermocoagulation therapy of liver tumors: initial clinical experiences using a.5 T open MR system. J Magn Reson Imaging. 2002;16:576–83.CrossRefPubMed
17.
Zurück zum Zitat Sato K, Morikawa S, Inubushi T, Kurumi Y, Naka S, Haque HA, et al. Alternate biplanar MR navi- gation for microwave ablation of liver tumors. Magn Reson Med Sci. 2005;4:89–94.CrossRefPubMed Sato K, Morikawa S, Inubushi T, Kurumi Y, Naka S, Haque HA, et al. Alternate biplanar MR navi- gation for microwave ablation of liver tumors. Magn Reson Med Sci. 2005;4:89–94.CrossRefPubMed
18.
Zurück zum Zitat Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Demura K, et al. Feasibility of respiratory triggering for MR-guided microwave ablation of liver tumors under general anesthesia. Cardiovasc Intervent Radiol. 2004;27:370–3.PubMed Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Demura K, et al. Feasibility of respiratory triggering for MR-guided microwave ablation of liver tumors under general anesthesia. Cardiovasc Intervent Radiol. 2004;27:370–3.PubMed
19.
Zurück zum Zitat Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Tani T, et al. New assistive devices for MR-guided microwave thermocoagulation of liver tumors. Acad Radiol. 2003;10:180–8.CrossRefPubMed Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Tani T, et al. New assistive devices for MR-guided microwave thermocoagulation of liver tumors. Acad Radiol. 2003;10:180–8.CrossRefPubMed
20.
Zurück zum Zitat Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Demura K, et al. Advanced computer assistance for magnetic resonance-guided microwave thermocoagulation of liver tumors. Acad Radiol. 2003;10:1442–9.CrossRefPubMed Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Demura K, et al. Advanced computer assistance for magnetic resonance-guided microwave thermocoagulation of liver tumors. Acad Radiol. 2003;10:1442–9.CrossRefPubMed
21.
Zurück zum Zitat Kurumi Y, Tani T, Naka S, Shiomi H, Shimizu T, Abe H, et al. MR-guided microwave ablation for malignancies. Int J Clin Oncol. 2007;12:85–93.CrossRefPubMed Kurumi Y, Tani T, Naka S, Shiomi H, Shimizu T, Abe H, et al. MR-guided microwave ablation for malignancies. Int J Clin Oncol. 2007;12:85–93.CrossRefPubMed
22.
Zurück zum Zitat Tabuse K. A new operative procedure of hepatic surgery using a microwave tissue coagulator. Nippon Geka Hokan. 1979;48:160–72.PubMed Tabuse K. A new operative procedure of hepatic surgery using a microwave tissue coagulator. Nippon Geka Hokan. 1979;48:160–72.PubMed
23.
Zurück zum Zitat Murakami R, Yoshimatsu S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR Am J Roentgenol. 1995;164(5):1159–64.CrossRefPubMed Murakami R, Yoshimatsu S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR Am J Roentgenol. 1995;164(5):1159–64.CrossRefPubMed
24.
Zurück zum Zitat Laeseke PF, Lee FT, Sampson LA, van der Weide DW, Brace CL. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol. 2009;20(9):1224–9.PubMedCentralCrossRefPubMed Laeseke PF, Lee FT, Sampson LA, van der Weide DW, Brace CL. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol. 2009;20(9):1224–9.PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Okamoto T, Onda S, Yanaga K, Suzuki N, Hattori A. Clinical application of navigation surgery using augmented reality in the abdominal field. Surg Today 2014 (Online First). Okamoto T, Onda S, Yanaga K, Suzuki N, Hattori A. Clinical application of navigation surgery using augmented reality in the abdominal field. Surg Today 2014 (Online First).
26.
Zurück zum Zitat Shiomi H, Naka S, Sato K, Demura K, Murakami K, Shimizu T, et al. Thoracoscopy-assisted magnetic resonance guided microwave coagulation therapy for hepatic tumors. Am J Surg. 2008;195(6):854–60.CrossRefPubMed Shiomi H, Naka S, Sato K, Demura K, Murakami K, Shimizu T, et al. Thoracoscopy-assisted magnetic resonance guided microwave coagulation therapy for hepatic tumors. Am J Surg. 2008;195(6):854–60.CrossRefPubMed
28.
Zurück zum Zitat Mukaisho K, Kurumi Y, Sugihara H, Naka S, Kamitani S, Tsubosa Y, et al. Enzyme histochemistry is useful to assess viability of tumor tissue after microwave coagulation therapy (MCT): metastatic adenocarcinoma treated by lateral segmentectomy after MCT. Dig Dis Sci. 2002;47(11):2441–5.CrossRefPubMed Mukaisho K, Kurumi Y, Sugihara H, Naka S, Kamitani S, Tsubosa Y, et al. Enzyme histochemistry is useful to assess viability of tumor tissue after microwave coagulation therapy (MCT): metastatic adenocarcinoma treated by lateral segmentectomy after MCT. Dig Dis Sci. 2002;47(11):2441–5.CrossRefPubMed
29.
Zurück zum Zitat Yamaguchi T, Mukaisho K, Yamamoto H, Shiomi H, Kurumi Y, Sugihara H, et al. Disruption of erythrocytes distinguishes fixed cells/tissues from viable cells/tissues following microwave coagulation therapy. Dig Dis Sci. 2005;50:1347–55.CrossRefPubMed Yamaguchi T, Mukaisho K, Yamamoto H, Shiomi H, Kurumi Y, Sugihara H, et al. Disruption of erythrocytes distinguishes fixed cells/tissues from viable cells/tissues following microwave coagulation therapy. Dig Dis Sci. 2005;50:1347–55.CrossRefPubMed
30.
Zurück zum Zitat Murakami K, Morikawa S, Naka S, Demura K, Sato K, Shiomi H, et al. Correlation between high field MR images and histopathological findings of rat transplanted cancer immediately after partial microwave coagulation. Magn Reson Med Sci. 2008;7(3):105–12.CrossRefPubMed Murakami K, Morikawa S, Naka S, Demura K, Sato K, Shiomi H, et al. Correlation between high field MR images and histopathological findings of rat transplanted cancer immediately after partial microwave coagulation. Magn Reson Med Sci. 2008;7(3):105–12.CrossRefPubMed
31.
Zurück zum Zitat Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Demura K, et al. Advanced computer assistance for magnetic resonance-guided microwave thermocoagulation of liver tumors. Acad Radiol. 2013;10(12):1442–9.CrossRef Morikawa S, Inubushi T, Kurumi Y, Naka S, Sato K, Demura K, et al. Advanced computer assistance for magnetic resonance-guided microwave thermocoagulation of liver tumors. Acad Radiol. 2013;10(12):1442–9.CrossRef
32.
Zurück zum Zitat Simo KA, Sereika SE, Newton KN, Gerber DA. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation. J Surg Oncl. 2011;104:822–9.CrossRef Simo KA, Sereika SE, Newton KN, Gerber DA. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation. J Surg Oncl. 2011;104:822–9.CrossRef
Metadaten
Titel
Initial experiences with MR Image-guided laparoscopic microwave coagulation therapy for hepatic tumors
verfasst von
Koichiro Murakami
Shigeyuki Naka
Hisanori Shiomi
Hiroya Akabori
Yoshimasa Kurumi
Shigehiro Morikawa
Tohru Tani
Publikationsdatum
01.09.2015
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 9/2015
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-014-1042-x

Weitere Artikel der Ausgabe 9/2015

Surgery Today 9/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 49 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Diabetestechnologie für alle?

15.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Eine verbesserte Stoffwechseleinstellung und höhere Lebensqualität – Diabetestechnologien sollen den Alltag der Patienten erleichtern. Dass CGM, AID & Co. bei Typ-1-Diabetes helfen, ist belegt. Bei Typ-2 gestaltet sich die Sache komplizierter.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.